Shalimar International P Ltd
⚠️ Moderate Risk
FEI: 3004458369 • New Delhi • INDIA
FEI Number
3004458369
Location
New Delhi
Country
INDIAAddress
Safdarjung Enclave, , New Delhi, , India
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
FILTHY
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the article appears to consist in whole or in part of a filthy, putrid, or decomposed substance or be otherwise unfit for food.
Refusal History
Frequently Asked Questions
What is Shalimar International P Ltd's FDA import refusal history?
Shalimar International P Ltd (FEI: 3004458369) has 2 FDA import refusal record(s) in our database, spanning from 11/9/2005 to 11/9/2005.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Shalimar International P Ltd's FEI number is 3004458369.
What types of violations has Shalimar International P Ltd received?
Shalimar International P Ltd has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Shalimar International P Ltd come from?
All FDA import refusal data for Shalimar International P Ltd is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.